INTRODUCTION
Coronary Artery Disease is the leading cause of death worldwide. The level of low-density lipoprotein cholesterol (LDL-C) is one of the primary key predictor of atherosclerosis and coronary heart disease (CHD) risk. [1] [2] [3] There is a strong positive association between increased LDL-C and CHD. 3 LDL-cholesterol is used in clinical decision making guidelines to reducing cardiovascular risk events. 1 According to National Cholesterol Education Programme's (NCEP) Adult Treatment Panel III (ATP III) recommendations LDL-C is a primary risk factor for cardiovascular disease (CVD).
2 About 1% reduction in LDL can reduce the risk of CAD by 1%. 4 Pakistani population is also at high risk of increasing incidence of Coronary Artery Disease (CAD). 2 
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Measured versus calculated LDL-cholesterol in subjects with Type 2 Diabetes
Patients with diabetes mellitus are considered as a high risk for cardiovascular disease. 5 Abnormal lipid profiles and increased levels of low density lipoproteins (LDL) are two components of the atherogenic profile seen in diabetes mellitus. 6, 7 In the view of all above findings the accuracy of LDL-C estimation is essential and critically important. 3 Inaccurate estimation LDL-C can cause misclassification of patients into an inappropriate risk category. The reference method for measurement of LDL-C concentration combines with ultra centrifugationpolianion precipitation/Beta Quantification (ßQ). [2] [3] [4] A new but somewhat expensive measured homogenous assays for LDL-C determination in serum also certified by NCEP and Cholesterol Reference Method Laboratory Network of Centre for Disease Control and Prevention for use in routine clinical laboratories is also available.
2,3
The aim of present study was to compare calculated LDL-C with measured homogeneous assay in patients with type 2 diabetes. Hypertension: Hypertension was defined as blood pressure >130/85 mmHg. This category includes patients taking antihypertensive medicines, even if treatment achieves a blood pressure level that is within target range. Biochemical tests: Biochemical analyses were carried out at clinical and research laboratory of BIDE. Blood was collected by venepuncture from all subjects using sterilized disposable vaccutainer needles in gel (for lipids), Sodium fluoride (for glucose) and EDTA K2 (for HbA1c) containing vaccutainer tubes. Blood glucose (GOD PAP method): Fasting blood glucose was determined after enzymatic oxidation in the presence of glucose oxidase. The hydrogen peroxide formed reacts, under catalysis of peroxidase with phenol and 4-aminophenazone to form a red violet quinoneimine dye as indicator.
METHODS

This
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Total cholesterol (CHOD-PAP method): Serum total cholesterol in Cholesterol was determined after enzymatic hydrolysis and oxidation, indicator quinoneimine is formed from hydrogen peroxide and 4-aminoantipyrine in the presence of phenol and peroxidase.
2,10
Triglyceride (GPO-PAP method): Triglycerides were determined after enzymatic hydrolysis with lipases. The indicator was a quinoneimine formed from hydrogen peroxide, 4-aminop-henazone and 4-cholorophenol under the under the catalytic influence of peroxidase.
HDL-cholesterol (Homogeneous enzymatic colorimetric method): HDL-cholesterol Immuno FS, a homogenous method for HDL-cholesterol measurement.
Antibodies against human lipoproteins were used to form antigen -antibody complexes with LDL (low density lipoproteins), VLDL (very low density lipoproteins) and Chylomicrons in a way that only HDL-cholesterol is selectively determined by an enzymatic cholesterol measurement.
LDL-cholesterol (Direct method): There are two steps involve in the estimation of LDL cholesterol by direct method. In first step, when a sample mixed with reagent 1 (MES buffer, ph 6.3, detergent 1, cholesterol esterase, cholesterol oxidase, peroxidase, 4-Amino-Antipyrine and ascorbic acid), non LDL lipoproteins are solubilized by detergent one and release cholesterol is subject to enzymatic reaction to be eliminated. In 2 nd step reagent 2 (MES buffer, ph 6.3, detergent 2, N,N-bism-tolidine-disodium) is added, LDL is solubilized by detergent 2, then LDL cholesterol is measured by enzymatic reactions. . Independent t-test or chisquare test were used for finding difference between male and female group for anthropometric, clinical and lipid variables, whereas paired t-test was used to find mean difference between measured and calculated LDL-C. P<0.05 was considered statistically significant.
RESULTS
Anthropometric
characteristics of study population are shown in Table-I. A total of 9620 subjects (5425 males and 4195 females) were included in the study. Mean ages of study subjects LDL-cholesterol in subjects with Type 2 Diabetes Data presented as Mean ± S.D or n (%) * Denotes p-value < 0.05 P-value <0.05 was considered statistically significant.
Fig.1: Comparison of measured and calculated LDL-C (by formula)
. P-value < 0.05 was considered statistically significant. P-value was found to be statistically significant in all cases.
was 50.54 ± 11.86, male 51.06 ± 11.89 and female 49.86 ± 11.78 years. BMI was found to be statistically significant (p<0.05). Systolic blood pressure was significantly higher in male diabetics as compare to female diabetic subjects (p<0.05). The mean of total cholesterol and HDL cholesterol was found to be statistically significant (p<0.05). All the variables had statistically significant difference except for triglyceride and HbA1c. Fig.1 shows the comparison of measured and calculated LDL-C in male and female subjects. It was observed that the measured LDL-C of the female diabetic patients was statistically significant as compare to male diabetic patients (p<0.05). The situation remains same in case of overall analysis.
Comparison of measured LDL-C and calculated LDL-C at different triglyceride levels are shown in Table- II. At low triglycerides levels, measured LDL-C and calculated LDL-C levels were 97.40 ± 32.87 and 97.65 ± 36.16 mg/dl respectively, having no statistically significant difference. But when triglycerides level ranges from 150 to 400 mg/dl, a significant increase in mean difference between measured LDL-C (115.71 ± 35.62 mg/dl) and calculated LDL-C level (109.08 ± 41.64 mg/dl) was found to be 6.63 ± 26.43 mg/dl. This difference then increases to 46.55 ± 55.36 mg/dl as triglyceride level is beyond 400 mg/dl (p<0.0001).
DISCUSSION
The most important finding of our study on patients with diabetes mellitus is that the Friedewald equation tends to underestimate LDL-C. Friedewald formula is commonly used in most of routine clinical laboratories for the estimation of LDL-C. Various direct assays also developed to measure LDL-C. 2, 11, 12 The determination of LDL-C is essential for the assessment of risk of cardiovascular disease and the treatment of dyslipidemia which is mostly based on strategies reducing LDL concentration, therefore LDL-C should be estimated accurately. The comparison of measured LDL-C and calculated LDL-C has shown different findings in different studies. Our study shows that calculated LDL-C by Friedewald formula underestimates the LDL level as compare to directly measured LDL-C at crucial points where accuracy is very essential. Same results were found in some other studies. [1] [2] [3] [4] 13, 14 Choi SY et al., found in their study that Friedewald formula extremely correlated with directly measured LDL-C, but the difference between two LDL-C values was approximately 11.51 mg/dl. 15 Boshtam M et al., study demonstrated the Friedewald formula overestimated the LDL-C levels compared to the direct measurement method. 16 According to Chai Kheng EY et al., in multiethnic Asian study population the negative bias of LDL-C is important especially when directly measured LDL-C is near the lower LDL-C cut-off used for risk categorization by using the Friedewald equation. 1 Choi SY et al., suggest that alternative measurements of LDL-C could confuse clinicians especially in patients with diabetes mellitus. 15 But according to Anwar M et al., many patients were classified in wrong NCEP cardiac risk categories by calculated methods of LDL-C determination. Data presented as Mean±S.D P-value < 0.05 was considered statistically significant. Fig.2 : Frequency of dyslipidemia, obesity and hypertensive subjects. P-value < 0.05 was considered statistically significant P-value was found to be statistically significant in all cases.
The negative bias of Friedewald-derived LDL-C was noted even at desirable triglyceride levels. Friedewald formula is very good at normal triglyceride levels and provides accurate results. 2, 11, 12, 17 The calculated methods did not have a uniform performance for LDL-C estimation at different triglyceride levels. 2 Higher the triglyceride concentration, higher the negative bias in the Friedewald formula was observed. 13 There was no statistically significant difference in calculated and measured LDL-C at triglyceride levels < 150 mg/dl, however, mean difference reached 6.63 and 46.55 at triglyceride levels between 150-400 mg/dl and >400 mg/dl respectively in our study. Same findings obtained from some other studies. 2, 4, [11] [12] [13] 16, 18 This underestimation of LDL-C by calculated methods increased as triglyceride levels increased and many patients were classified in wrong cardiac risk categories. The direct assays are precise, accurate and not affected by triglyceride levels, therefore, should be used to measure LDL-C. 2 The difference in direct and calculated LDL-C depends on serum triglyceride. 15, 19, 20 The LDL derived from Friedewald equation is significantly underestimated at triglyceride concentrations >177 mg/dl. 13, 16, 18 In another study, at triglyceride concentrations 177 mg/dl, the average LDL calculated by Friedewald equation was already 28% lower than direct LDL.
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CONCLUSION
The findings of the study suggest that calculated LDL-C underestimates measured LDL-C, which may cause misclassifications that may have an impact on therapeutic decisions in patients with diabetes. Calculated LDL-C may depend on triglyceride levels hence LDL-C should be measured by direct assay in routine clinical laboratories.
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